Stay updated with breaking news from Patrick Henno. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cell-Easy SAS ("Cell-Easy"), a rapidly growing Contract Development and Manufacturing Organization ("CDMO") that specializes in cell therapy, has appointed Dr. Sebastien Ribault, PhD, to its board
TOULOUSE, France--(BUSINESS WIRE)--Cell-Easy SAS (“Cell-Easy”), a rapidly growing Contract Development and Manufacturing Organization (“CDMO”) that specializes in cell therapy, has appointed Dr. Sebastien Ribault, PhD, to its board of directors, to further accelerate its growth.Cell-Easy is a leading contract develo...
Emercell SAS (Emercell) and Cell-Easy SAS (Cell-Easy) announced today the signing of a strategic agreement for the scale-up and manufacturing of Emercell's lead product. This press release features
EPALINGES, Switzerland and MONTPELLIER, France, June 20, 2022 /PRNewswire/ -- Onward Therapeutics SA (Onward Therapeutics) and Emercell SAS (Emerc...
(1) EMERCell, a biotechnology company developing immunotherapies and cell-based therapies for oncology targets through to pharmaceutical development, announces the signature of a strategic partnership with Onward Therapeutics. The significant investment, of a confidential amount, will be made in three instalments that will allow EMERCell to reach the first human clinical trials. "We are delighted to partner with Onward Therapeutics, whose teams have recognized expertise in the development of new drugs in oncology and with whom we have strong synergies. Their participation is a recognition of ...